Show simple item record

dc.contributor.authorKrishna, Mamidipudi Thirumala
dc.contributor.authorMahesh, Padukudru Anand
dc.contributor.authorVedanthan, Pudupakkam
dc.contributor.authorMoitra, Saibal
dc.contributor.authorMehta, Vinay
dc.contributor.authorChristopher, Devasahayam Jesudas
dc.date.accessioned2024-11-21T15:40:30Z
dc.date.available2024-11-21T15:40:30Z
dc.date.issued2020-08-01
dc.identifier.citationKrishna MT, Mahesh PA, Vedanthan P, Moitra S, Mehta V, Christopher DJ. An appraisal of allergic disorders in India and an urgent call for action. World Allergy Organ J. 2020 Aug 1;13(7):100446. doi: 10.1016/j.waojou.2020.100446en_US
dc.identifier.issn1939-4551
dc.identifier.doi10.1016/j.waojou.2020.100446
dc.identifier.pmid32774662
dc.identifier.urihttp://hdl.handle.net/20.500.14200/6576
dc.description.abstractIndia is the second most populous country in the world with a population of nearly 1.3 billion, comprising 20% of the global population. There are an estimated 37.5 million cases of asthma in India, and recent studies have reported a rise in prevalence of allergic rhinitis and asthma. Overall, 40-50% of paediatric asthma cases in India are uncontrolled or severe. Treatment of allergic rhinitis and asthma is sub-optimal in a significant proportion of cases due to multiple factors relating to unaffordability to buy medications, low national gross domestic product, religious beliefs, myths and stigma regarding chronic ailment, illiteracy, lack of allergy specialists, and lack of access to allergen-specific immunotherapy for allergic rhinitis and biologics for severe asthma. High quality allergen extracts for skin tests and adrenaline auto-injectors are currently not available in India. Higher postgraduate specialist training programmes in Allergy and Immunology are also not available. Another major challenge for the vast majority of the Indian population is an unacceptably high level of exposure to particulate matter (PM)2.5 generated from traffic pollution and use of fossil fuel and biomass fuel and burning of incense sticks and mosquito coils. This review provides an overview of the burden of allergic disorders in India. It appraises current evidence and justifies an urgent need for a strategic multipronged approach to enhance quality of care for allergic disorders. This may include creating an infrastructure for education and training of healthcare professionals and patients and involving regulatory authorities for making essential treatments accessible at subsidised prices. It calls for research into better phenotypic characterisation of allergic disorders, as evidence generated from high income western countries are not directly applicable to India, due to important confounders such as ethnicity, air pollution, high rates of parasitic infestation, and other infections.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.urlhttps://link.springer.com/journal/40413en_US
dc.rights© 2020 Published by Elsevier Inc. on behalf of World Allergy Organization.
dc.subjectRespiratory medicineen_US
dc.titleAn appraisal of allergic disorders in India and an urgent call for action.en_US
dc.typeArticleen_US
dc.typeOtheren_US
dc.source.journaltitleThe World Allergy Organization Journalen_US
dc.source.volume13
dc.source.issue7
dc.source.beginpage100446
dc.source.endpage
dc.source.countryUnited States
rioxxterms.versionNAen_US
dc.contributor.trustauthorKrishna, Thirumala
dc.contributor.departmentPathologyen_US
dc.contributor.roleMedical and Dentalen_US
oa.grant.openaccessnaen_US


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record